|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dawson MA and Kouzarides T: Cancer
epigenetics: From mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Migheli F and Migliore L: Epigenetics of
colorectal cancer. Clin Genet. 81:312–318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feinberg AP and Tycko B: The history of
cancer epigenetics. Nat Rev Cancer. 4:143–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sahnane N, Magnoli F, Bernasconi B,
Tibiletti MG, Romualdi C, Pedroni M, Ponz de Leon M, Magnani G,
Reggiani-Bonetti L, Bertario L, et al: AIFEG: Aberrant DNA
methylation profiles of inherited and sporadic colorectal cancer.
Clin Epigenetics. 7:1312015. View Article : Google Scholar
|
|
6
|
Baylin SB, Herman JG, Graff JR, Vertino PM
and Issa JP: Alterations in DNA methylation: A fundamental aspect
of neoplasia. Adv Cancer Res. 72:141–196. 1998. View Article : Google Scholar
|
|
7
|
Robertson KD, Uzvolgyi E, Liang G,
Talmadge C, Sumegi J, Gonzales FA and Jones PA: The human DNA
methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression
in normal tissues and overexpression in tumors. Nucleic Acids Res.
27:2291–2298. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rangel-Salazar R, Wickström-Lindholm M,
Aguilar-Salinas CA, Alvarado-Caudillo Y, Døssing KB, Esteller M,
Labourier E, Lund G, Nielsen FC, Rodríguez-Ríos D, et al: Human
native lipoprotein-induced de novo DNA methylation is associated
with repression of inflammatory genes in THP-1 macrophages. BMC
Genomics. 12:5822011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mori Y, Ishiguro H, Kuwabara Y, Kimura M,
Mitsui A, Ogawa R, Katada T, Harata K, Tanaka T, Shiozaki M, et al:
MicroRNA-21 induces cell proliferation and invasion in esophageal
squamous cell carcinoma. Mol Med Rep. 2:235–239. 2009.PubMed/NCBI
|
|
12
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu
HM, Zhang X, Jiang L, Xing CZ and Zhang Y: MicroRNA-148b is
frequently down-regulated in gastric cancer and acts as a tumor
suppressor by inhibiting cell proliferation. Mol Cancer. 10:12011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matsubara N: Epigenetic regulation and
colorectal cancer. Dis Colon Rectum. 55:96–104. 2012. View Article : Google Scholar
|
|
15
|
Wu WK, Law PT, Lee CW, Cho CH, Fan D, Wu
K, Yu J and Sung JJ: MicroRNA in colorectal cancer: From benchtop
to bedside. Carcinogenesis. 32:247–253. 2011. View Article : Google Scholar
|
|
16
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Egeblad M, Nakasone ES and Werb Z: Tumors
as organs: Complex tissues that interface with the entire organism.
Dev Cell. 18:884–901. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weber CE and Kuo PC: The tumor
microenvironment. Surg Oncol. 21:172–177. 2012. View Article : Google Scholar
|
|
19
|
Paulsen JE, Namork E, Steffensen IL, Eide
TJ and Alexander J: Identification and quantification of aberrant
crypt foci in the colon of Min mice - a murine model of familial
adenomatous polyposis. Scand J Gastroenterol. 35:534–539. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Serrano M, Hannon GJ and Beach D: A new
regulatory motif in cell-cycle control causing specific inhibition
of cyclin D/CDK4. Nature. 366:704–707. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin RJ, Lubpairee T, Liu KY, Anderson DW,
Durham S and Poh CF: Cyclin D1 overexpression is associated with
poor prognosis in oropharyngeal cancer. J Otolaryngol Head Neck
Surg. 42:232013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ren B, Li W, Yang Y and Wu S: The impact
of cyclin D1 overexpression on the prognosis of bladder cancer: A
meta-analysis. World J Surg Oncol. 12:552014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
24
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar
|
|
25
|
Snásel J, Shoeman R, Horejsí M,
Hrusková-Heidingsfeldová O, Sedlácek J, Ruml T and Pichová I:
Cleavage of vimentin by different retroviral proteases. Arch
Biochem Biophys. 377:241–245. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hondo T, Kanaya T, Takakura I, Watanabe H,
Takahashi Y, Nagasawa Y, Terada S, Ohwada S, Watanabe K, Kitazawa
H, et al: Cytokeratin 18 is a specific marker of bovine intestinal
M cell. Am J Physiol Gastrointest Liver Physiol. 300:G442–G453.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singh S, Sadacharan S, Su S, Belldegrun A,
Persad S and Singh G: Overexpression of vimentin: Role in the
invasive phenotype in an androgen-independent model of prostate
cancer. Cancer Res. 63:2306–2311. 2003.PubMed/NCBI
|
|
28
|
Previati M, Manfrini M, Galasso M,
Zerbinati C, Palatini J, Gasparini P and Volinia S: Next generation
analysis of breast cancer genomes for precision medicine. Cancer
Lett. 339:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen XY, He QY and Guo MZ: XAF1 is
frequently methylated in human esophageal cancer. World J
Gastroenterol. 18:2844–2849. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao XY, Ma HX, Shang YH, Jin MS, Kong F,
Jia ZF, Cao DH, Wang YP, Suo J and Jiang J: DNA methyltransferase3a
expression is an independent poor prognostic indicator in gastric
cancer. World J Gastroenterol. 20:8201–8208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Seidel C, Florean C, Schnekenburger M,
Dicato M and Diederich M: Chromatin-modifying agents in anti-cancer
therapy. Biochimie. 94:2264–2279. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Walton EL, Francastel C and Velasco G:
Maintenance of DNA methylation: Dnmt3b joins the dance.
Epigenetics. 6:1373–1377. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Van Emburgh BO and Robertson KD:
Modulation of Dnmt3b function in vitro by interactions with Dnmt3L,
Dnmt3a and Dnmt3b splice variants. Nucleic Acids Res. 39:4984–5002.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ooi SK, O'Donnell AH and Bestor TH:
Mammalian cytosine methylation at a glance. J Cell Sci.
122:2787–2791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schnekenburger M and Diederich M:
Epigenetics Offer New Horizons for Colorectal Cancer Prevention.
Curr Colorectal Cancer Rep. 8:66–81. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Florean C, Schnekenburger M, Grandjenette
C, Dicato M and Diederich M: Epigenomics of leukemia: From
mechanisms to therapeutic applications. Epigenomics. 3:581–609.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kanai Y and Hirohashi S: Alterations of
DNA methylation associated with abnormalities of DNA
methyltransferases in human cancers during transition from a
precancerous to a malignant state. Carcinogenesis. 28:2434–2442.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Karius T, Schnekenburger M, Ghelfi J,
Walter J, Dicato M and Diederich M: Reversible epigenetic
fingerprint-mediated glutathione-S-transferase P1 gene silencing in
human leukemia cell lines. Biochem Pharmacol. 81:1329–1342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
van Engeland M, Derks S, Smits KM, Meijer
GA and Herman JG: Colorectal cancer epigenetics: Complex
simplicity. J Clin Oncol. 29:1382–1391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vaiopoulos AG, Athanasoula KC and
Papavassiliou AG: Epigenetic modifications in colorectal cancer:
Molecular insights and therapeutic challenges. Biochim Biophys
Acta. 1842:971–980. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yoneyama K, Ishibashi O, Kawase R, Kurose
K and Takeshita T: miR-200a, miR-200b and miR-429 are onco-miRs
that target the PTEN gene in endometrioid endometrial carcinoma.
Anticancer Res. 35:1401–1410. 2015.PubMed/NCBI
|
|
42
|
Roy S and Majumdar AP: Cancer stem cells
in colorectal cancer: genetic and epigenetic changes. J Stem Cell
Res Ther. (Suppl 7): pii: 10342.
|
|
43
|
Tost J: DNA methylation: An introduction
to the biology and the disease-associated changes of a promising
biomarker. Mol Biotechnol. 44:71–81. 2010. View Article : Google Scholar
|
|
44
|
Hammoud SS, Cairns BR and Jones DA:
Epigenetic regulation of colon cancer and intestinal stem cells.
Curr Opin Cell Biol. 25:177–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Choong MK and Tsafnat G: Genetic and
epigenetic biomarkers of colorectal cancer. Clin Gastroenterol
Hepatol. 10:9–15. 2012. View Article : Google Scholar
|
|
46
|
Mima K, Nishihara R, Qian ZR, Cao Y,
Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, et al:
Fusobacterium nucleatum in colorectal carcinoma tissue and patient
prognosis. Gut. Aug 26–2015.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tahara T, Yamamoto E, Suzuki H, Maruyama
R, Chung W, Garriga J, Jelinek J, Yamano HO, Sugai T, An B, et al:
Fusobacterium in colonic flora and molecular features of colorectal
carcinoma. Cancer Res. 74:1311–1318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ogino S, Lochhead P, Chan AT, Nishihara R,
Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs
CS, et al: Molecular pathological epidemiology of epigenetics:
Emerging integrative science to analyze environment, host, and
disease. Mod Pathol. 26:465–484. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Potter JD: Morphogens, morphostats,
microarchitecture and malignancy. Nat Rev Cancer. 7:464–474. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: A role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995;
discussion 5995. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
González-Ramírez I, Soto-Reyes E,
Sánchez-Pérez Y, Herrera LA and García-Cuellar C: Histones and long
non-coding RNAs: The new insights of epigenetic deregulation
involved in oral cancer. Oral Oncol. 50:691–695. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Robertson KD: DNA methylation and human
disease. Nat Rev Genet. 6:597–610. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li J, Jin H and Wang X: Epigenetic
biomarkers: potential applications in gastrointestinal cancers.
ISRN Gastroenterology. 2014:4640152014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
